As key metabolic regulators, SCFAs influence adipose tissue metabolism, lipid oxidation, β-cell function, and insulin secretion, suggesting a microbiota-SCFA-metabolism relationship and their potential as therapeutic targets for obesity and related diseases [27,28,29]. This evidence concerns the gene INS and obesity disorder.